Source:http://linkedlifedata.com/resource/pubmed/id/12173321
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
2002-8-13
|
pubmed:abstractText |
The authors previously found the I1307K adenomatous polyposis coli (APC) gene variant in 5% of Ashkenazi control participants, in 15.4% of those who had familial colorectal neoplasia, but also in 1.6% of non-Ashkenazi control participants. In this study, they evaluated its use in a screening program for familial colorectal neoplasia and examined for a founder effect.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0008-543X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
94
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2561-8
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:12173321-Adult,
pubmed-meshheading:12173321-Aged,
pubmed-meshheading:12173321-Aged, 80 and over,
pubmed-meshheading:12173321-Colorectal Neoplasms,
pubmed-meshheading:12173321-Female,
pubmed-meshheading:12173321-Founder Effect,
pubmed-meshheading:12173321-Genes, APC,
pubmed-meshheading:12173321-Genetic Variation,
pubmed-meshheading:12173321-Humans,
pubmed-meshheading:12173321-Israel,
pubmed-meshheading:12173321-Jews,
pubmed-meshheading:12173321-Male,
pubmed-meshheading:12173321-Middle Aged
|
pubmed:year |
2002
|
pubmed:articleTitle |
Clinical and screening implications of the I1307K adenomatous polyposis coli gene variant in Israeli Ashkenazi Jews with familial colorectal neoplasia. Evidence for a founder effect.
|
pubmed:affiliation |
Department of Gastroenterology, Tel Aviv Medical Center, 6 Weizmann Street, 64239 Tel Aviv, Israel. rozen@tasmc.health.gov.il
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|